AAK AB (publ.) Earnings Call Transcripts
Fiscal Year 2026
-
Organic volume growth and strong profitability were achieved despite FX headwinds, with operating profit up 11% at fixed rates and robust cash flow. Strategic investments and disciplined execution continue, while cautious market conditions and FX volatility persist.
Fiscal Year 2025
-
Operating profit grew 9% at constant FX in 2025, with strong profitability despite 2% lower volumes. The board proposes higher dividends and a SEK 3 billion share buyback, while cost savings and disciplined capital allocation support long-term growth.
-
Q3 2025 saw 9% operating profit growth at fixed FX, strong profitability, and sequential volume gains despite currency headwinds and soft demand in some segments. Strategic investments, cost optimization, and resilient sourcing underpin a positive long-term outlook.
-
Operating profit rose 16% at fixed FX, driven by margin improvements and optimization, despite a 2% volume decline. Strong cash flow, robust ROCE, and ongoing cost-saving initiatives support a positive long-term outlook.
-
Q1 2025 saw resilient operating profit despite a 5% volume decline, with strong margin gains in key segments and continued progress in sustainability. A cost optimization program was launched, targeting SEK 300 million in annual savings by mid-2026.
Fiscal Year 2024
-
Q4 2024 saw 11% operating profit growth and a 2% volume increase for the year, driven by optimization and favorable market conditions. The board proposes a 35% higher dividend, and the company maintains a strong balance sheet with a positive outlook for 2025.
-
Q3 2024 saw 4% volume growth and an 18% increase in operating profit at fixed currencies, driven by strong performance in chocolate and confectionery fats and ongoing optimization. The divestment of the U.S. food service site and new investments in Europe are set to enhance margins and operational focus.
-
Q2 2024 delivered 4% volume growth and a 27% rise in operating profit, driven by strong performance in Chocolate & Confectionery Fats and Food Ingredients, with continued investments in sustainability and regulatory compliance. Leverage remains low and return on capital employed is robust.